PIWI-interacting RNAs: new biomarkers for diagnosis and treatment of breast cancer

• Main Authors: Parisa Maleki Dana, Mohammad Ali Mansournia, Seyyed Mehdi Mirhashemi
• Format: Article
• Language: English
• Published: BMC 2020-03-01
• Series: Cell & Bioscience
• Subjects: piRNA; Breast cancer; Epigenetic regulations
• Online Access: http://link.springer.com/article/10.1186/s13578-020-00403-5

Abstract Cancer is one of the most important reasons of mortality in the world. However, there are several therapeutic platforms to treat patients who suffering from cancer common treatments such as surgery, chemotherapy and etc. The current therapeutic approaches are related to some limitations. Hence, more understanding about molecular mechanisms that involved in cancer particularly in breast cancer pathogenesis, could contribute to provide better therapeutic platforms. Recently, non-coding RNAs such as microRNAs have attracted researchers’ attention in the field of cancer due to their functions in gene expression’s regulation and functional interactions with other molecules. Interestingly, great advances in next-generation sequencing lead to considering other roles for another non-coding RNAs subgroup called PIWI-interacting RNAs (piRNAs) in addition to their functions in the germline. Novel studies investigated the role of piRNAs in several cancers including lung cancer, hepatocellular carcinoma, gastric cancer, multiple myeloma and colorectal cancer. Hopefully, based on new findings, piRNAs may be a potential biomarker which can be used as a tool to diagnose or treat breast cancer. Thus, this review aimed to discuss the role of piRNAs in breast cancer progression and metastasis as well as its molecular mechanisms.